Literature DB >> 25131654

Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant.

Bhakti Mehta1, Kris Mahadeo, Re Zaw, Shinyi Tang, Neena Kapoor, Hisham Abdel-Azim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25131654     DOI： 10.1002/pbc.25172

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  7 in total

1.  Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome.

Authors:  H Shima; K Isshiki; Y Yamada; F Yamazaki; T Takahashi; H Shimada
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

2.  Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases.

Authors:  Ehud Even-Or; Yael Dinur Schejter; Adeeb NaserEddin; Irina Zaidman; Bella Shadur; Polina Stepensky
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 3.  Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors:  Zhengrui Xiao; Irina Murakhovskaya
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

Review 4.  Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders.

Authors:  Ashish O Gupta; Jaap Jan Boelens; Christen L Ebens; Joanne Kurtzberg; Troy C Lund; Angela R Smith; John E Wagner; Robert Wynn; Bruce R Blazar; Paul J Orchard
Journal:  Bone Marrow Transplant       Date:  2021-01-13       Impact factor: 5.174

Review 5.  B cells in autoimmune hepatitis: bystanders or central players?

Authors:  Christoph Schultheiß; Silja Steinmann; Ansgar W Lohse; Mascha Binder
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

6.  Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.

Authors:  Amanda M DiNofia; Elizabeth Salazar; Alix E Seif; Yimei Li; Yuan-Shung Vera Huang; Rochelle Bagatell; Brian T Fisher; Richard Aplenc
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

Review 7.  Targeting B Cells and Plasma Cells in Autoimmune Diseases.

Authors:  Katharina Hofmann; Ann-Katrin Clauder; Rudolf Armin Manz
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.